• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients".

作者信息

Kemp Bohan Phillip M, Nelson Daniel W

机构信息

Department of Surgery, Brooke Army Medical Center, 3551 Roger Brooke Dr., Fort Sam Houston, San Antonio, TX, 78234, USA.

Department of Surgery, William Beaumont Army Medical Center, 5005 N. Piedras St., El Paso, TX, 79920, USA.

出版信息

Ann Surg Oncol. 2020 Dec;27(Suppl 3):942-943. doi: 10.1245/s10434-020-09170-6. Epub 2020 Sep 25.

DOI:10.1245/s10434-020-09170-6
PMID:32978701
Abstract
摘要

相似文献

1
Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients".
Ann Surg Oncol. 2020 Dec;27(Suppl 3):942-943. doi: 10.1245/s10434-020-09170-6. Epub 2020 Sep 25.
2
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.尽管辅助化疗对淋巴结阳性的可切除胆囊癌患者有益，但仍未得到充分利用。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):940-941. doi: 10.1245/s10434-020-09167-1. Epub 2020 Sep 28.
3
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.可切除胆囊癌的辅助化疗尽管可使淋巴结阳性患者获益，但仍未得到充分应用。
Ann Surg Oncol. 2021 Mar;28(3):1466-1480. doi: 10.1245/s10434-020-08973-x. Epub 2020 Aug 4.
4
Cheek metastasis from gallbladder adenocarcinoma.
J Visc Surg. 2013 Jun;150(3):225-6. doi: 10.1016/j.jviscsurg.2013.03.012. Epub 2013 May 10.
5
Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma.识别出在意外胆囊癌切除术后最可能受益于辅助化疗的患者。
J Surg Oncol. 2021 Mar;123(4):978-985. doi: 10.1002/jso.26389. Epub 2021 Jan 26.
6
[A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy].[一例胆囊癌伴腹膜后淋巴结复发对优福定与顺铂联合化疗有效的病例]
Gan To Kagaku Ryoho. 1994 May;21(6):881-4.
7
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.术后辅助化疗对胆囊癌是否有用？一项针对已切除胰胆管癌患者的III期多中心前瞻性随机对照试验。
Cancer. 2002 Oct 15;95(8):1685-95. doi: 10.1002/cncr.10831.
8
[A Case of Metachronous Liver Metastasis of Gallbladder Cancer Successfully Treated by Hepatectomy after Chemotherapy].[1例胆囊癌异时性肝转移经化疗后肝切除成功治疗的病例]
Gan To Kagaku Ryoho. 2020 Oct;47(10):1501-1504.
9
Chemotherapy for gallbladder carcinoma--a surgeon's perspective.胆囊癌的化疗——外科医生的观点
Hepatogastroenterology. 2000 Jul-Aug;47(34):948-55.
10
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09).辅助化疗 S-1 治疗淋巴结阳性胆道癌（N-SOG 09）的 2 期临床试验。
Ann Surg Oncol. 2020 Jul;27(7):2348-2356. doi: 10.1245/s10434-020-08355-3. Epub 2020 Mar 16.

引用本文的文献

1
ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer.ASO作者反思：淋巴结清扫术对非转移性胆囊癌生存影响的当代分析
Ann Surg Oncol. 2021 Jun;28(6):2973-2974. doi: 10.1245/s10434-021-09668-7. Epub 2021 Feb 9.
2
ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data.ASO作者反思：辅助化疗在胆囊癌切除术后的趋势及影响：超越试验数据
Ann Surg Oncol. 2021 Mar;28(3):1481-1482. doi: 10.1245/s10434-020-08979-5. Epub 2020 Aug 5.